22 February 2010 - Recipharm has announced that, following the successful acquisition of Cobra Biomanufacturing, it has combined it with the existing Biologics activities located in Sweden.
The integrated business will be known as Recipharm Cobra Biologics and will operate as Recipharm's specialist biologics division.
